Obsessive-compulsive symptoms with risperidone.
Mahendran
R
R
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced*; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
D014150:Antipsychotic Agents; D005473:Fluoxetine; D018967:Risperidone; D017367:Selective Serotonin Reuptake Inhibitors; D014635:Valproic Acid